Letter to the Editor
Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials

https://doi.org/10.1016/j.jaci.2017.04.015Get rights and content

First page preview

First page preview
Click to open first page preview

Cited by (0)

This work was supported by the National Natural Science Foundation of China (grant nos. 81371735, 81573045, 81573038, and 81600201), the Natural Science Foundation of Jiangsu province (grant no. BK20151066), Open Grant of the Jiangsu provincial Key Laboratory of Molecular Biology for Skin Diseases and STIs (grant no. 2015KF14), and the Milstein Medical Asian American Partnership Foundation.

Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.

These authors contributed equally to this work.

View full text